The U.S. has wasted more than 82 million COVID vaccine doses. Public health experts said the waste is alarming since less than half of fully vaccinated Americans have a booster shot and many poorer countries continue to struggle with vaccine supply. (NBC News

A small rectal cancer trial found remission in every patient. The results, which were sponsored by GSK, marked the first time a treatment completely obliterated a cancer in every patient, according to one of the study’s lead researchers. (The New York Times)

Novavax is awaiting its COVID vaccine review from the Food and Drug Administration’s advisory panel. The vaccine could provide the U.S. with another option if it receives a thumbs-up from the FDA and the Centers for Disease Control and Prevention. (Atlanta Journal-Constitution)

After weeks of short supply, Abbott has reopened its baby formula plant. The company said it will prioritize EleCare and other specialty and metabolic formulas, which will be available to consumers as early as June 20. (Fox Business)

AstraZeneca announced at ASCO 2022 that its breast cancer drug beat expectations. The company said its antibody-drug Enhertu reduced the risk of disease progression or death by half vis-a-vis patients who received chemotherapy. (Barron’s)